6Vazquez Nava F, Salas Ramirez E, Mogica Mogica Jde D, et al. Prevalence and risk factors for allergic conjunctivitis in children. Comparative study in two communities [J]. Rec Alery mex, 2002, 49 (2):33-41.
7Berdy GJ, Stoppel JO, Epstein AB. Comparison of the clinical efficacy and tolerability of olopatadine hydrochloride 0.1% ophthalmic solution and loteprednol etabonate 0.2% ophthalmie suspension in the conjunetival allergen challenge model [J]. Clin Ther, 2002, 24 (6): 918-929.
